Jessica Protenic

Senior Director of Patient Services | Registered Nurse

Role: Senior Director of Patient Services at Longeveron
Location: Miami, FL, US
LinkedIn followers: 500 followers

Healthcare & Human ServicesView LinkedIn profile

About Jessica Protenic

At Longeveron Inc, the focus has been on leading a dedicated team in delivering…

Experience

Senior Director of Patient Services
Longeveron
Sep 2021 — Present · Miami, FL, US

Education

West Chester University of Pennsylvania
Bachelor's degree
2009 — 2012
Drexel University
Bachelor of Science (BS)
2012 — 2013
West Chester East
High School
2003 — 2007

Skills

Irb
Acls
Customer Service
Communication
Microsoft Office
Sales
Social Media
Patient Safety
Patient Education
Training
Nursing
Bls
Time Management
Patient Support
Organization
Clinical Trials
Microsoft Excel
Powerpoint
Patient Recruitment
Critical Thinking
Healthcare
Research
Nutrition
Social Networking
Patient Advocacy
Leadership
Cooking
Clinical Research
Gcp

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
j••••••••@longeveron.com
Personal email
•••••@•••••.com
Direct dial
+14•••••••97

Unlock verified contacts

Free to start · No credit card required

Current company

Longeveron

Biotechnology · 41 employees · Founded 2014 · Miami, Florida, United States

We are a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions. Our lead investigational product is laromestrocel (Lomecel-B™), which is derived from culture-expanded mesenchymal stem cells (MSCs) that are sourced from bone marrow of young healthy adult donors. We believe that by using the same cells that promote tissue repair, organ maintenance, and immune system function, we can develop safe and effective therapies for some of the most difficult diseases and conditions associated with aging. Our clinical development programs have delivered several positive initial results across 5 clinical trials in 3 indications: Phase 1 & 2 in Alzheimer’s Disease, Phase 1 & 2 in Aging-related Frailty, Phase 1 in Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric disease. We are currently conducting a pivotal Phase2b clinical trial in HLHS. Our mission is to advance laromestrocel (Lomecel-B™) and other cell-based product candidates into pivotal trials, with the goal of achieving regulatory approvals, subsequent commercialization and broad use by the healthcare community. Our philosophy is that healthy aging can be improved through regenerative medicine approaches. Life expectancy has substantially increased over the past century as a result of medical and public health advancements. However, this increase in longevity has not been paralleled by the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging – a period known as healthspan. As we age, we experience a profound decline, in both number and function, in our own MSCs, a decrease in immune system function, decline in blood vessel functioning, chronic inflammation and other issues. Our clinical data suggest that laromestrocel (Lomecel-B™) addresses these conditions through multiple mechanisms of action, or MOAs, that target key aging-related processes

longeveron.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Jessica Protenic

Experience

Senior Director of Patient Services

Education

West Chester University of Pennsylvania

Drexel University

West Chester East

Skills

Find verified contacts for anyone on LinkedIn